CLINICAL_TRIALS
trial_result
· 2013-11-26
Clinical Trial Update: Zoledronic Acid in MS-patients With Osteoporosis [Phase 3]
Summary
A Phase 3 trial of zoledronic acid in multiple sclerosis patients with osteoporosis was terminated; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Osteoporosis, Multiple Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2013-11-26